Announce Date | 09/18/2025 |
EPS Normalized Actual | $4.05 (Miss by $-0.08) |
EPS GAAP Actual | $4.05 (Miss by $-0.08) |
Revenue Actual | $0.596901B |
Revenue Surprise | Beat by $596.901M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Aug 2030 | 24.9 | 11.37 | 24.6267 | 25.26813 | 4 |
Aug 2029 | 23.95 | 11.82 | 23.49543 | 24.51647 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ3 2025 (Aug 2025) | 4.07 | 4.07 | 0.596901B | 5.82% | 596.9M |
FQ2 2025 (May 2025) | 3.92 | 3.92 | 0.58552B | 5.6% | 585.52M |
FQ1 2025 (Feb 2025) | 3.81 | 3.81 | 0.57066B | 4.33% | 570.66M |
FQ4 2024 (Nov 2024) | 3.95 | 3.95 | 0.568667B | 4.65% | 568.67M |
FQ3 2024 (Aug 2024) | 2.35 | 2.35 | 0.562187B | 4.69% | 562.19M |
FQ2 2024 (May 2024) | 4.15 | 4.15 | 0.552708B | 4.14% | 552.71M |
FQ1 2024 (Feb 2024) | 3.7 | 3.7 | 0.545945B | 5.65% | 545.95M |
FQ4 2023 (Nov 2023) | 3.91 | 3.91 | 0.542216B | 6.9% | 542.22M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2028 (May 2028) | 5.5382 | -- | 5.49911 | 5.60104 | 8 |
FQ1 2028 (Feb 2028) | 5.3617 | -- | 5.32386 | 5.42254 | 11 |
FQ4 2027 (Nov 2027) | 5.3192 | -- | 5.28166 | 5.37956 | 7 |
FQ3 2027 (Aug 2027) | 5.18004 | -- | 5.0767 | 5.21349 | 10 |
FQ2 2027 (May 2027) | 5.13154 | -- | 5.02917 | 5.16467 | 7 |
FQ1 2027 (Feb 2027) | 5.04031 | -- | 5.01554 | 5.06299 | 7 |
FQ4 2026 (Nov 2026) | 5.01307 | -- | 4.91306 | 5.04544 | 7 |
FQ3 2026 (Aug 2026) | 4.81797 | 15.52 | 4.745 | 4.86737 | 5 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2028 (May 2028) | 0.79B | -- | 0.78B | 0.79B | 6 |
FQ1 2028 (Feb 2028) | 0.77B | -- | 0.76B | 0.77B | 10 |
FQ4 2027 (Nov 2027) | 0.75B | -- | 0.74B | 0.75B | 12 |
FQ3 2027 (Aug 2027) | 0.66B | -- | 0.65B | 0.66B | 7 |
FQ2 2027 (May 2027) | 0.65B | -- | 0.64B | 0.65B | 12 |
FQ1 2027 (Feb 2027) | 0.64B | -- | 0.64B | 0.64B | 5 |
FQ4 2026 (Nov 2026) | 0.63B | -- | 0.63B | 0.64B | 7 |
FQ3 2026 (Aug 2026) | 0.65B | 7.77 | 0.64B | 0.65B | 9 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2025 (Aug 2025) | 4.07 | 4.07 | 100% | |
FQ2 2025 (May 2025) | 3.92 | 3.92 | 100% | |
FQ1 2025 (Feb 2025) | 3.81 | 3.81 | 100% | |
FQ4 2024 (Nov 2024) | 3.95 | 3.95 | 100% | |
FQ3 2024 (Aug 2024) | 2.35 | 2.35 | 100% | |
FQ2 2024 (May 2024) | 4.15 | 4.15 | 100% | |
FQ1 2024 (Feb 2024) | 3.7 | 3.7 | 100% | |
FQ4 2023 (Nov 2023) | 3.91 | 3.91 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2025 (Aug 2025) | $0B | $0.6B | $596.9M | 100% |
FQ2 2025 (May 2025) | $0B | $0.59B | $585.52M | 100% |
FQ1 2025 (Feb 2025) | $0B | $0.57B | $570.66M | 100% |
FQ4 2024 (Nov 2024) | $0B | $0.57B | $568.67M | 100% |
FQ3 2024 (Aug 2024) | $0B | $0.56B | $562.19M | 100% |
FQ2 2024 (May 2024) | $0B | $0.55B | $552.71M | 100% |
FQ1 2024 (Feb 2024) | $0B | $0.55B | $545.95M | 100% |
FQ4 2023 (Nov 2023) | $0B | $0.54B | $542.22M | 100% |